Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.17 USD | -4.68% | +11.27% | +44.66% |
Business Summary
Number of employees: 124
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Peptide-based Therapeutics
100.0
%
| 27 | 100.0 % | 60 | 100.0 % | +125.73% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 27 | 100.0 % | 60 | 100.0 % | +125.73% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 08-11-30 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 22-04-17 |
Chief Tech/Sci/R&D Officer | - | 17-06-30 | |
Samuel Saks
CTO | Chief Tech/Sci/R&D Officer | 69 | 18-05-23 |
Arturo Molina
CTO | Chief Tech/Sci/R&D Officer | 65 | 22-11-06 |
Craig Ostroff
LAW | General Counsel | - | - |
Carena Spivey
HRO | Human Resources Officer | - | - |
Suneel Gupta
PRN | Corporate Officer/Principal | 66 | 19-01-16 |
Ashok Bhandari
PRN | Corporate Officer/Principal | - | 16-12-31 |
Carter J. King
PRN | Corporate Officer/Principal | 52 | 18-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 17-06-07 |
Harold Selick
CHM | Chairman | 69 | 09-01-31 |
Daniel Swisher
BRD | Director/Board Member | 61 | 23-10-25 |
Dinesh Patel
CEO | Chief Executive Officer | 67 | 08-11-30 |
Sarah O'Dowd
BRD | Director/Board Member | 74 | 20-08-11 |
William Waddill
BRD | Director/Board Member | 67 | 16-06-30 |
Bryan Giraudo
BRD | Director/Board Member | 49 | 18-05-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,652,133 | 56,866,179 ( 96.96 %) | 0 | 96.96 % |
Company contact information
Protagonist Therapeutics, Inc.
7707 Gateway Boulevard Suite 140
94560-1160, Newark
+
http://www.protagonist-inc.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.77% | 2.04B | |
+51.85% | 57.87B | |
+41.53% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- PTGX Stock
- Company Protagonist Therapeutics, Inc.